161 related articles for article (PubMed ID: 35546589)
1. Assessing surveillance utilization and value in commercially insured patients with colorectal cancer.
Suh K; Shankaran V; Bansal A
Am J Manag Care; 2022 May; 28(5):e163-e169. PubMed ID: 35546589
[TBL] [Abstract][Full Text] [Related]
2. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
3. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer.
Vargas GM; Sheffield KM; Parmar AD; Han Y; Brown KM; Riall TS
Surgery; 2013 Aug; 154(2):244-55. PubMed ID: 23889952
[TBL] [Abstract][Full Text] [Related]
4. Colonoscopy, imaging, and carcinoembryonic antigen: Comparison of guideline adherence to surveillance strategies in patients who underwent resection of colorectal cancer - A systematic review and meta-analysis.
Dawood ZS; Hamad A; Moazzam Z; Alaimo L; Lima HA; Shaikh C; Munir MM; Endo Y; Pawlik TM
Surg Oncol; 2023 Apr; 47():101910. PubMed ID: 36806402
[TBL] [Abstract][Full Text] [Related]
5. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis.
Sisler JJ; Seo B; Katz A; Shu E; Chateau D; Czaykowski P; Wirtzfeld D; Singh H; Turner D; Martens P
J Oncol Pract; 2012 Jul; 8(4):e69-79. PubMed ID: 23181004
[TBL] [Abstract][Full Text] [Related]
6. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
7. Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers.
Kupfer SS; Lubner S; Coronel E; Pickhardt PJ; Tipping M; Graffy P; Keenan E; Ross E; Li T; Weinberg DS
Cancer Med; 2018 Nov; 7(11):5351-5358. PubMed ID: 30338661
[TBL] [Abstract][Full Text] [Related]
8. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy.
Graham RA; Wang S; Catalano PJ; Haller DG
Ann Surg; 1998 Jul; 228(1):59-63. PubMed ID: 9671067
[TBL] [Abstract][Full Text] [Related]
9. Disparities in post-operative surveillance testing for metastatic recurrence among colorectal cancer survivors.
Sanchez JI; Shankaran V; Unger JM; Madeleine MM; Espinoza N; Thompson B
J Cancer Surviv; 2022 Jun; 16(3):638-649. PubMed ID: 34031803
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
Makis W; Kurzencwyg D; Hickeson M
Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
[TBL] [Abstract][Full Text] [Related]
11. Patient-clinician information engagement improves adherence to colorectal cancer surveillance after curative treatment: results from a longitudinal study.
Tan AS; Moldovan-Johnson M; Parvanta S; Gray SW; Armstrong K; Hornik RC
Oncologist; 2012; 17(9):1155-62. PubMed ID: 22858794
[TBL] [Abstract][Full Text] [Related]
12. Colorectal testing utilization and payments in a large cohort of commercially insured US adults.
Ladabaum U; Levin Z; Mannalithara A; Brill JV; Bundorf MK
Am J Gastroenterol; 2014 Oct; 109(10):1513-25. PubMed ID: 24980877
[TBL] [Abstract][Full Text] [Related]
13. The utility of surveillance CT scans in a cohort of survivors of colorectal cancer.
Braden J; Blinman P; Malalasekera A; Kerin-Ayres K; Spencer J; Southi N; Vardy JL
J Cancer Surviv; 2023 Aug; 17(4):1202-1210. PubMed ID: 35040075
[TBL] [Abstract][Full Text] [Related]
14. Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
Zhang Y; Feng B; Zhang GL; Hu M; Fu Z; Zhao F; Zhang XL; Kong L; Yu JM
World J Gastroenterol; 2014 Jun; 20(21):6608-14. PubMed ID: 24914384
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
Shinkins B; Nicholson BD; Primrose J; Perera R; James T; Pugh S; Mant D
PLoS One; 2017; 12(3):e0171810. PubMed ID: 28282381
[TBL] [Abstract][Full Text] [Related]
16. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.
Okamura R; Hasegawa S; Hida K; Hoshino N; Kawada K; Sugihara K; Sakai Y;
Int J Clin Oncol; 2017 Feb; 22(1):96-101. PubMed ID: 27503134
[TBL] [Abstract][Full Text] [Related]
17. Receipt of guideline-recommended follow-up in older colorectal cancer survivors : a population-based analysis.
Cooper GS; Kou TD; Reynolds HL
Cancer; 2008 Oct; 113(8):2029-37. PubMed ID: 18780338
[TBL] [Abstract][Full Text] [Related]
18. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
19. Patterns of surveillance for colorectal cancer: Experience from a single large tertiary institution.
Pellegrino SA; Chan S; Simons K; Kinsella R; Gibbs P; Faragher IG; Deftereos I; Yeung JM
Asia Pac J Clin Oncol; 2021 Aug; 17(4):343-349. PubMed ID: 33079492
[TBL] [Abstract][Full Text] [Related]
20. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
